Epcoritamab has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for B-cell Lymphomas in the third- or later-line setting for the treatment of patients with diffuse large B-cell lymphoma.
Guidelines | Diffuse Large B-Cell Lymphoma Guideline Updates 2023
Diffuse Large B-Cell Lymphoma Guideline Updates 2023
Articles
Videos
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
5